Effect of Dupilumab on patient-reported breathing and rescue medication use

J. Corren (Los Angeles, United States of America), M. Castro (Kansas City, United States of America), J. Maspero (Buenos Aires, Argentina), W. Busse (Madison, United States of America), A. Valero Santiago (Barcelona, Spain), P. Kuna (Lodz, Poland), N. Daizadeh (Cambridge, United States of America), N. Pandit-Abid (Bridgewater, United States of America), B. Ortiz (Tarrytown, United States of America), A. Khan (Chilly-Mazarin, France), S. Kamat (Tarrytown, United States of America)

Source: Virtual Congress 2020 – Management of allergy, asthma and COPD
Session: Management of allergy, asthma and COPD
Session type: E-poster session
Number: 233
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Corren (Los Angeles, United States of America), M. Castro (Kansas City, United States of America), J. Maspero (Buenos Aires, Argentina), W. Busse (Madison, United States of America), A. Valero Santiago (Barcelona, Spain), P. Kuna (Lodz, Poland), N. Daizadeh (Cambridge, United States of America), N. Pandit-Abid (Bridgewater, United States of America), B. Ortiz (Tarrytown, United States of America), A. Khan (Chilly-Mazarin, France), S. Kamat (Tarrytown, United States of America). Effect of Dupilumab on patient-reported breathing and rescue medication use. 233

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: